What EXACT SCIENCES CORP's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 4 |
| Total trades | 0 | 124 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 1,724,996 |
| Disposed | 0 | 3,319,235 |
| Net activity | +0 | −1,594,239 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Doyle James Edward | Director | Mar 23 | Disposition to Issuer · D | −5,398 | — | — | 0 |
| Doyle James Edward | Director | Mar 23 | Disposition to Issuer · D | −52,564 | — | — | 5,398 |
| Napier Katherine S | Director | Mar 23 | Disposition to Issuer · D | −5,398 | — | — | 0 |
| Napier Katherine S | Director | Mar 23 | Disposition to Issuer · D | −55,361 | — | — | 5,398 |
| Petrovic Shacey | Director | Mar 23 | Disposition to Issuer · D | −7,095 | — | — | 0 |
| Petrovic Shacey | Director | Mar 23 | Disposition to Issuer · D | −5,398 | — | — | 0 |
| Petrovic Shacey | Director | Mar 23 | Disposition to Issuer · D | −16,406 | — | — | 5,398 |
| Orville Jacob A | EVP, GM, Screening | Mar 23 | Disposition to Issuer · D | −1,774 | — | — | 0 |
| Orville Jacob A | EVP, GM, Screening | Mar 23 | Disposition to Issuer · D | −153,726 | — | — | 0 |
| Orville Jacob A | EVP, GM, Screening | Mar 23 | Grant / award · A | +53,323 | — | — | 153,726 |
| Condella Sarah | EVP, Human Resources | Mar 23 | Disposition to Issuer · D | −6,368 | — | — | 0 |
| Condella Sarah | EVP, Human Resources | Mar 23 | Disposition to Issuer · D | −191,891 | — | — | 0 |
| Condella Sarah | EVP, Human Resources | Mar 23 | Grant / award · A | +60,389 | — | — | 191,891 |
| Baranick Brian | EVP, GM, Precision Oncology | Mar 23 | Disposition to Issuer · D | −795 | — | — | 0 |
| Baranick Brian | EVP, GM, Precision Oncology | Mar 23 | Disposition to Issuer · D | −137,195 | — | — | 0 |
| Baranick Brian | EVP, GM, Precision Oncology | Mar 23 | Grant / award · A | +33,321 | — | — | 137,195 |
| Herriott James | SVP, General Counsel & Sec | Mar 23 | Disposition to Issuer · D | −1,762 | — | — | 0 |
| Herriott James | SVP, General Counsel & Sec | Mar 23 | Disposition to Issuer · D | −68,195 | — | — | 0 |
| Coward D Scott | Director | Mar 23 | Disposition to Issuer · D | −4,694 | — | — | 0 |
| Coward D Scott | Director | Mar 23 | Disposition to Issuer · D | −5,398 | — | — | 0 |
Loading...